Sera Prognostics (NASDAQ: SERA) has announced the appointment of Tiffany Inglis, MD, FACOG, as chief medical officer (CMO). Dr. Inglis brings extensive clinical leadership expertise to Sera. As CMO, she will lead...
William Blair launched coverage of Sera Prognostics (NASDAQ:SERA), a pregnancy diagnostics company, with an “outperform” rating. The stock closed at $12.85 on Aug. 6. Analyst Brian Weinstein writes that the current rate...